Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Slater

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
European Journal of Medicinal Chemistry|May 17, 2003
The design of potent, non-peptidic inhibitors of hepatitis C proteaseDavid M Andrews, Helene M Chaignot, Barry A Coomber, et al.
Organic Letters|November 25, 2003
Pyrrolidine-5,5-trans-lactams. 5. Pharmacokinetic optimization of inhibitors of hepatitis C virus NS3/4A proteaseDavid M Andrews, Michael C Barnes, Mike D Dowle, et al.
Journal of Medicinal Chemistry|January 30, 2025
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor ModelsGuillaume Dutheuil, Killian Oukoloff, Julien Korac, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenaseJason D Oliver, Graham E M Sibley, Nicola Beckmann, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
A non-canonical AKT1-TERT pathway coordinates autophagy and ERphagyVishnu Suresh Babu, Sayan Ghosh, Sridhar Bammidi, et al.
The Journal of Organic Chemistry|March 25, 2008
Asymmetric synthesis of an N-acylpyrrolidine for inhibition of HCV polymeraseArmel A Agbodjan, Bob E Cooley, Royston C B Copley, et al.
Journal of Medicinal Chemistry|February 3, 2007
Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidateMartin J Slater, Elizabeth M Amphlett, David M Andrews, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronatesXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2010
Synthesis and evaluation of novel alpha-amino cyclic boronates as inhibitors of HCV NS3 proteaseXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Medicinal Chemistry|May 17, 2003
The design of potent, non-peptidic inhibitors of hepatitis C proteaseDavid M Andrews, Helene M Chaignot, Barry A Coomber, et al.
Organic Letters|November 25, 2003
Pyrrolidine-5,5-trans-lactams. 5. Pharmacokinetic optimization of inhibitors of hepatitis C virus NS3/4A proteaseDavid M Andrews, Michael C Barnes, Mike D Dowle, et al.
Journal of Medicinal Chemistry|January 30, 2025
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor ModelsGuillaume Dutheuil, Killian Oukoloff, Julien Korac, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenaseJason D Oliver, Graham E M Sibley, Nicola Beckmann, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
A non-canonical AKT1-TERT pathway coordinates autophagy and ERphagyVishnu Suresh Babu, Sayan Ghosh, Sridhar Bammidi, et al.
The Journal of Organic Chemistry|March 25, 2008
Asymmetric synthesis of an N-acylpyrrolidine for inhibition of HCV polymeraseArmel A Agbodjan, Bob E Cooley, Royston C B Copley, et al.
Journal of Medicinal Chemistry|February 3, 2007
Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidateMartin J Slater, Elizabeth M Amphlett, David M Andrews, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronatesXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2010
Synthesis and evaluation of novel alpha-amino cyclic boronates as inhibitors of HCV NS3 proteaseXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Pageof 2